Search

Clinical Articles September 2001
... Populations were determined from Statistics Canada data.[ 2 ] We used the mean of the number of cardiologists listed by ... will be attracted to the province. A population growth of 2% per year in BC was used. The predicted number of ... study results are summarized here in  Table 1 ,  Table 2 , and  Figure 1 . Limitations  The model used to predict ...
Clinical Articles / BY: Hugh Freeman, MD, FRCPC, FACP, FACG September 2001
... could cause impaired fat absorption in these patients.[ 2,3 ] Between 1954 and 1960, the intestinal histopathological ... increased numbers of intra-epithelial lymphocytes ( Figure 2 ).[ 7 ] A number of small intestinal disorders may have a ... subtle presentations of celiac disease also occur ( Table 2 ). Celiac disease may be clinically occult in some ...
BC Centre for Disease Control / BY: Joseph Noone, MD, LRCP&SI, FRCPC September 2001
... violence prevention working group and enlist support Step 2 Conduct a risk assessment Step 3 Develop and implement ... prevention and management of aggressive behavior. Level 2. Control and restraint training This can be provided as a 1- or 2-day workshop and includes basic self-protection training, ...
Letters / BY: Michael Alms, MB September 2001
... to my letter published in your March issue [ BCMJ 2001;43(2): 68 ] and Dr Mador’s comments that appeared in June [ ...
Clinical Articles / BY: Diana Carter, MBBS October 2001
... the menses than they are after menstruation has ceased. [ 2,3] Epidemiology of the menopause Large epidemiological ...
Clinical Articles / BY: Darlene M.S. Hammell, MD October 2001
... to women, especially to those at highest risk for CHD. [ 2]  This belief was based on the large body of observational ... estrogen (0.625 mg) and medroxyprogesterone acetate (2.5 mg) to placebo. The HERS Research Group studied 2763 ... an overall increase in venous thromboembolic events (RR 2.89) and gallbladder disease (RR 1.38) in the HRT group. ...
Clinical Articles / BY: R.C. Offer, MD, FRCPC, FACR October 2001
... efficacy for estrogen replacement therapy or etidronate. [ 2] Advising women about osteoporosis The primary-care ... a low T-score and no secondary causes for this ( Table 2 ), rarely suffers fragility fractures. She does, however, ... regimen. Quick-fix alendronate would be 10 mg daily for 2 years or, based on more recent data, 70 mg once a week [ ...
Clinical Articles / BY: Suzanne Montemuro, MD, CCFP October 2001
... from distressing symptoms that affect their busy lives. [ 2-6]  Those having the most severe symptoms are most likely ... menopause approaches, menses become less frequent (every 2 to 3 months) and symptoms such as hot flushes (also ... been evaluated in 23 randomized controlled trials (from 2 to 4 months in duration) involving patients with mild to ...
Clinical Articles / BY: B. Strauss, RN, BScN, MSc November 2001
... since a 1997 review of measles infection and IBD [ 2]  and, if the title or abstract referred to both MMR ... of autism and MMR vaccination within the following 1 to 2 years (RI 1.09 [95% CI = 0.76–1.52]). Furthermore, from a ... year and subsequent ulcerative colitis (OR 7.47, 95% CI = 2.42–23.06) and Crohn’s disease (OR 4.27, 95% CI = ...
Clinical Articles / BY: Timothy C. Rowe, MBBS, FRCSC, FRCOG November 2001
... but it appears to have no endometrial effect. [ 2]   Please see  Table 2  and  Table 3 . Methods of use Postmenopausal women who ... mg daily) and medroxyprogesterone acetate (most commonly 2.5 mg daily). This combination is marketed in the United ...